Levin M E, Hatfull G F
Department of Biological Sciences, University of Pittsburgh, Pennsylvania 15260.
Mol Microbiol. 1993 Apr;8(2):277-85. doi: 10.1111/j.1365-2958.1993.tb01572.x.
We have isolated RNA polymerase from Mycobacterium smegmatis and established conditions for specific transcription initiation in vitro. The M. smegmatis enzyme has a strong dependence on supercoiling of the DNA substrate for transcription from mycobacterial promoters. We also show that RNA polymerase is the target for rifampicin, and that this antibiotic specifically inhibits the transition from synthesis of short oligoribonucleotides to full-length transcripts. RNA polymerase isolated from a rifampicin-resistant mutant of M. smegmatis is less sensitive to rifampicin in vitro, confirming that one mechanism of rifampicin resistance in mycobacteria is through alteration of RNA polymerase. This in vitro transcription system provides a simple method for the characterization of gene expression in mycobacteria including the pathogens Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium leprae. It also provides a system for evaluating potential anti-mycobacterial drugs.
我们从耻垢分枝杆菌中分离出了RNA聚合酶,并建立了体外特异性转录起始的条件。耻垢分枝杆菌的这种酶在从分枝杆菌启动子进行转录时,对DNA底物的超螺旋有很强的依赖性。我们还表明RNA聚合酶是利福平的作用靶点,并且这种抗生素能特异性抑制从短寡核糖核苷酸合成到全长转录本的转变。从耻垢分枝杆菌的利福平抗性突变体中分离出的RNA聚合酶在体外对利福平的敏感性较低,这证实了分枝杆菌中利福平抗性的一种机制是通过RNA聚合酶的改变。这种体外转录系统为包括结核分枝杆菌、鸟分枝杆菌和麻风分枝杆菌等病原体在内的分枝杆菌基因表达特征分析提供了一种简单方法。它还提供了一个评估潜在抗分枝杆菌药物的系统。